絞り込み

16638

広告

「"de Lima Lopes G"[Author]」の検索結果

39件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer.

Global Health Perspective in Sarcomas and Other Rare Cancers.

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway.

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

Chimeric antigen receptor T cells, a savior with a high price.

The Concept of Biosimilars: From Characterization to Evolution-A Narrative Review.

Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives.

Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations.

Can biosimilars help achieve the goals of US health care reform?

Thinking Differently in Global Health in Oncology Using a Diagonal Approach: Harnessing Similarities, Improving Education, and Empowering an Alternative Oncology Workforce.

The Road to Addressing Noncommunicable Diseases and Cancer in Global Health Policy.

Global Health Initiatives of the International Oncology Community.

A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma.

P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894): Track: Immunotherapy.

Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States.

A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker.

The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis.

Cervical cancer control in Latin America: A call to action.

Progress and remaining challenges for cancer control in Latin America and the Caribbean.

  1. 1
  2. 2
Sort by
※並べ替えは表示に時間がかかります